Waleed Alduaij

Originally from Kuwait, I am fortunate to have trained at several institutions across the world. I completed my MD PhD in 2012 at the University of Manchester, United Kingdom. My PhD was in the field of oncology and targeted therapy. My research focused on the mechanism of action of monoclonal antibodies in B-cell malignancies, mentored by Professor Tim Illidge.

After briefly working as a medical intern in Kuwait, I pursued a residency in internal medicine at the University of Toronto from 2015 to 2018, during which I conducted a clinical research project on the role of targeted sequencing gene panels in the management of myeloproliferative neoplasms at the Princess Margaret Cancer Centre supervised by Dr. Vikas Gupta. I then completed my hematology fellowship at UBC from 2018 to 2020.

I am currently pursuing a postdoctoral fellowship as part of the UBC Clinician Investigator Program. My current research focuses on the clinical outcomes and genomic characterization of a subset of highly aggressive lymphomas, referred to as “double hit” lymphomas, supervised by Dr. David Scott. In my free time, I enjoy dining out and savoring BC’s beauty on my bike (when it’s not raining!).

For an up-to-date list of Waleed’s publications, see ResearchGate.